A series of 7-chloro-2,3-disubstituted-4(3H)-quinazolinones (4a-j) were synthesized by the reaction of 3-amino-7-chloro-2-phenylquinazolin-4(3H)-one (3) with various amines in presence of formaldehyde. The starting material for the compounds was 2-amino-4-chloro benzoic acid. The structures of the compounds were characterized by IR, 1 H NMR, elemental analyses. Docking analysis of quinazolinone derivatives was done with DNA gyrase protein which was carried out by means of the AutoDockTools (ADT) v 1.5.4 and AutoDock v 4.2 programs. All compounds interacted with DNA gyrase protein. Preclinical evaluation of the compounds was ascertained by in silico toxicity, blood-brain barrier and drug like properties. All compounds were investigated for their antibacterial activity. Overall, compound (4b) showed better properties as a drug like candidate.
In our effort to identify potent anti-inflammatory and analgesic agents a number of 7-chloro-3-substituted-2-phenylquinazolin-4(3H)-ones have been synthesized starting from 4-chloro anthranilic acid. Docking analysis of the quinazolinone derivatives were done with COX-II protein which was carried out by means of the AutoDock program. Their structures have been elucidated on the basis of elemental analyses and spectroscopic studies (IR, 1H-NMR, MS). The synthesized compounds were tested for their analgesic activity by tail-flick method and anti-inflammatory activity by carrageenan induced rat paw oedema method. Preliminary evaluation of the anti-inflammatory and analgesic properties of the prepared compounds has indicated that some of them exhibit moderate to significant activity, compared to diclofenac standard.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.